Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06378892
Title A Study to Evaluate the Combination of Platinum-pemetrexed Based Chemotherapy Plus Lorlatinib in ALK Positive Non-Small Cell Lung Cancer (NSCLC) With Exclusively Extracranial Disease Progression on Lorlatinib (ALK-PPL)
Acronym ALK-PPL
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Centro di Riferimento Oncologico - Aviano
Indications
Therapies
Age Groups: adult | senior
Covered Countries ITA

Facility Status City State Zip Country Details
Centro di Riferimento Oncologico (CRO) IRCCS RECRUITING Aviano 33081 Italy Details
Azienda Ospedaliero-Universitaria Careggi Oncologia Medica NOT_YET_RECRUITING Firenze 50134 Italy Details
Azienda USL Toscana Nord Ovest Oncologia Medica, Ospedale Versilia NOT_YET_RECRUITING Lido Di Camaiore 55049 Italy Details
Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino amadori" NOT_YET_RECRUITING Meldola 47014 Italy Details
Fondazione IRCCS San Gerardo dei Tintori NOT_YET_RECRUITING Monza 20900 Italy Details
IOV Istituto Oncologico Veneto IRCCS NOT_YET_RECRUITING Padova 35128 Italy Details
Azienda Ospedaliero-Universitaria di Parma NOT_YET_RECRUITING Parma 43126 Italy Details
Azienda Ospedaliera di Perugia NOT_YET_RECRUITING Perugia 06129 Italy Details
Azienda Sanitaria Universitaria Friuli Centrale (ASU FC) NOT_YET_RECRUITING Udine 33010 Italy Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field